“Updated Integrated Safety Analysis of Ritlecitinib up to ~5 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials”. SKIN The Journal of Cutaneous Medicine, vol. 9, no. 6, Nov. 2025, p. s669, https://doi.org/10.25251/2vrcdb23.